GLP-1 drugs: India's regulatory authorities take firm steps to prevent unsupervised use
New Delhi, April 1 (IANS) The Drug Controller General of India has stepped up regulatory surveillance against unauthorised sale and promotion of type 2 diabetes drugs also known as GLP-1 drugs, the government said on Wednesday.